Literature DB >> 26093200

Choice of measures of vaccination and estimates of risk of pediatric pertussis.

Neal D Goldstein1, E Claire Newbern2, Alison A Evans3, Kate Drezner2, Seth L Welles3.   

Abstract

BACKGROUND: Vaccination uptake at the individual level can be assessed in a variety of ways, including traditional measures of being up-to-date (UTD), measures of UTD that consider dose timing, like age-appropriate vaccination, and risk reduction from individual doses. This analysis compared methods of operationalizing vaccination uptake and corresponding risk of pertussis infection.
METHODS: City-wide case-control study of children in Philadelphia aged 3 months through 6 years, between 2001 and 2013. Multiple logistic regression was used to isolate the independent effects of each measure of vaccination uptake and the corresponding relative odds of pertussis.
RESULTS: Being UTD on vaccinations was associated with a 52% reduction in risk of pertussis (OR 0.48, 95% CI: 0.34, 0.69). Evaluation of delayed receipt of vaccine versus on-time UTD yielded similar results. There was a decrease in risk of pertussis for each additional dose received with the greatest reduction in pertussis infection observed from the first (OR 0.48, 95% CI: 0.28, 0.83) and second dose (OR 0.17, 95% CI: 0.08, 0.34). Additional doses conferred minimal additional protection in this age group.
CONCLUSION: Examining vaccination status by individual doses may offer improved predictive capacity for identifying children at risk for pertussis infection compared to the traditional UTD measure.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bordatella pertussis; DTaP; Immunization; Pediatric; Whooping cough

Mesh:

Substances:

Year:  2015        PMID: 26093200     DOI: 10.1016/j.vaccine.2015.06.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children.

Authors:  Girishanthy Krishnarajah; Elisabetta Malangone-Monaco; Liisa Palmer; Ellen Riehle; Philip O Buck
Journal:  Hum Vaccin Immunother       Date:  2018-08-29       Impact factor: 3.452

2.  Operationalizing outcome measures of human papillomavirus vaccination among adolescents.

Authors:  C Odoh; M Sanderson; E A Williams; P C Hull
Journal:  Public Health       Date:  2018-03-30       Impact factor: 2.427

3.  Infant vaccination timing: Beyond traditional coverage metrics for maximizing impact of vaccine programs, an example from southern Nepal.

Authors:  Michelle M Hughes; Joanne Katz; Janet A Englund; Subarna K Khatry; Laxman Shrestha; Steven C LeClerq; Mark Steinhoff; James M Tielsch
Journal:  Vaccine       Date:  2016-01-11       Impact factor: 3.641

4.  Impact of vaccine delays at the 2, 4, 6 and 12 month visits on incomplete vaccination status by 24 months of age in Quebec, Canada.

Authors:  Marilou Kiely; Nicole Boulianne; Denis Talbot; Manale Ouakki; Maryse Guay; Monique Landry; Chantal Sauvageau; Gaston De Serres
Journal:  BMC Public Health       Date:  2018-12-11       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.